Genetic risk factors for portopulmonary hypertension in patients with advanced liver disease.
about
Portopulmonary hypertension: an updatePulmonary vascular complications of liver diseaseThe genetics of pulmonary arterial hypertensionNovel signaling pathways in pulmonary arterial hypertension (2015 Grover Conference Series)Pulmonary Arterial Hypertension and the Sex Hormone Paradox.Oestradiol metabolism and androgen receptor genotypes are associated with right ventricular functionGender, Estrogen, and Obliterative Lesions in the Lung.Sex differences in the pulmonary circulation: implications for pulmonary hypertensionPlasma levels of S100A4 in portopulmonary hypertensionDevelopment of pulmonary arterial hypertension in women: interplay of sex hormones and pulmonary vascular disease.Intronic SNP in ESR1 encoding human estrogen receptor alpha is associated with brain ESR1 mRNA isoform expression and behavioral traitsSaudi Guidelines on the Diagnosis and Treatment of Pulmonary Hypertension: Portopulmonary hypertensionGenetic polymorphism in a VEGF-independent angiogenesis gene ANGPT1 and overall survival of colorectal cancer patients after surgical resectionMetabolic and hormonal derangements in pulmonary hypertension: from mouse to man.Sex-dependent influence of endogenous estrogen in pulmonary hypertension.Estrogens and development of pulmonary hypertension: interaction of estradiol metabolism and pulmonary vascular disease.Pulmonary hypertension in women.Effectiveness of phosphodiesterase-5 inhibitor therapy for portopulmonary hypertension.Sex and haemodynamics in pulmonary arterial hypertension.Sex affects bone morphogenetic protein type II receptor signaling in pulmonary artery smooth muscle cells.Rescuing the BMPR2 signaling axis in pulmonary arterial hypertensionThe genetics of pulmonary arterial hypertension in the post-BMPR2 era.Update on pulmonary hypertension 2009.Statement on pregnancy in pulmonary hypertension from the Pulmonary Vascular Research Institute.Estrogen paradox in pulmonary hypertension: current controversies and future perspectives.Oestrogen receptor alpha in pulmonary hypertension.SRC-1 Regulates Blood Pressure and Aortic Stiffness in Female Mice.Estrogen Metabolite 16α-Hydroxyestrone Exacerbates Bone Morphogenetic Protein Receptor Type II-Associated Pulmonary Arterial Hypertension Through MicroRNA-29-Mediated Modulation of Cellular MetabolismHepatic Shunting of Eggs and Pulmonary Vascular Remodeling in Bmpr2(+/-) Mice with Schistosomiasis.Toward Precision Medicine in Pulmonary Arterial HypertensionHigher Estradiol and Lower Dehydroepiandrosterone-Sulfate Levels Are Associated with Pulmonary Arterial Hypertension in Men.Estrogens in Men: Another Layer of Complexity of Estradiol Metabolism in Pulmonary HypertensionAlterations in oestrogen metabolism: implications for higher penetrance of familial pulmonary arterial hypertension in females.Gender, sex hormones and pulmonary hypertension.Genetic variation in phosphodiesterase (PDE) 7B in chronic lymphocytic leukemia: overview of genetic variants of cyclic nucleotide PDEs in human disease.Macrophage migration inhibitory factor as a novel biomarker of portopulmonary hypertension.Mammalian target of rapamycin complex 2 (mTORC2) coordinates pulmonary artery smooth muscle cell metabolism, proliferation, and survival in pulmonary arterial hypertension.Pulmonary arterial hypertension: basis of sex differences in incidence and treatment response.Pulmonary vascular complications of chronic liver disease: Pathophysiology, imaging, and treatment.Review article: liver transplantation for the pulmonary disorders of portal hypertension.
P2860
Q27000393-86FEC598-573C-4F8E-8E29-0B928A82278DQ27021918-115A2E64-67A6-4EA4-95F2-7F436AE3E3F8Q27027507-82277368-2437-4B44-A09A-568955BF17CFQ28078976-7EA1AC14-21C8-4D08-8A2A-7A8ED1743726Q30241478-F21FCBFC-6280-4A62-9B7A-F9C259C5AE7DQ30277940-FAD69D1D-45BD-4A54-A5E2-FB5D024C1CDEQ33567156-9C382797-EE23-4951-9A87-B31C7CDC1159Q33568826-6A23B715-D59D-417F-A763-7F7F4282450BQ33642831-30A06EFB-2A08-4BFA-8384-8853ED3703DBQ33786374-63B1C8B1-5712-418E-8063-30DF5AA4E7BBQ33803212-3DEB8FED-2F60-40DD-9EB5-9FA6F3A9AA62Q33965877-CE3B7EDD-8687-46B2-AF86-85CCA63DA379Q34230336-CE144D1A-A37A-4B8F-BAAF-ED055540F693Q34245617-D839BFD9-9E5F-47A2-9EB3-AA05123D0DF4Q34425976-5C19D232-6509-4281-891E-A8E26BDB5DBAQ34524900-A8BEC9E9-4378-4528-A6EA-EE64654C6F5DQ34795939-C0960600-F193-43E2-80AA-11E7FB329385Q35073135-099A9BA6-56BC-4003-B8DA-ADBD1B2080F4Q35116055-7A02F2DD-11AD-43A7-9E31-5ABEDD56EEEBQ35262038-022F3550-B693-407C-846E-73C936808C2BQ35410950-443ECE97-4BE8-40A0-A35C-8E6EAEC753CFQ35573919-CDC0F5BA-DF70-4B7C-99AF-BD6503F59711Q35716098-87854422-7279-423C-ABA1-5B2C77792629Q36016478-5053DE33-F527-4173-B5C0-B11EA5352B43Q36120117-B8018ADD-BC6F-48F6-9EFE-A4E52078757CQ36191733-E9DF9426-D167-4093-B909-48743339F141Q36231819-76E5EE00-04A2-44E0-9CFA-602D085BBA75Q36421287-99A7782E-AB7C-4F4C-913E-5EE91C45C953Q36516808-98070E02-28FA-49BA-9778-8172959E0CA0Q36516839-C5176397-EC6B-4200-851E-CF3C0749604FQ36916062-3D84BF0A-A279-4EAD-A1BC-950C175F4925Q36916102-59BC1D7E-FDA7-45EC-A226-42E5FB380380Q37091591-FC20AB3E-D730-4019-9F0D-2829498569E1Q37133789-547EAEE8-808A-4FA6-B778-6822748F0E58Q37323162-06A8ADAB-2742-456B-B12D-E17AF7A928CFQ37555387-F177C8E7-8BFC-4C58-8A43-AC37A05249C7Q37670612-3A064935-EB30-4CB5-9A48-C7245E790BA8Q37671277-60769FE1-F711-4253-8158-5D4A15BD3B68Q37875682-B0DDE0E9-06D0-4DD3-85A8-2EE5957E0DFCQ38059261-5C7660FA-F20A-4DD9-9177-281E6F2779F8
P2860
Genetic risk factors for portopulmonary hypertension in patients with advanced liver disease.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 12 February 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Genetic risk factors for porto ...... s with advanced liver disease.
@en
Genetic risk factors for porto ...... s with advanced liver disease.
@nl
type
label
Genetic risk factors for porto ...... s with advanced liver disease.
@en
Genetic risk factors for porto ...... s with advanced liver disease.
@nl
prefLabel
Genetic risk factors for porto ...... s with advanced liver disease.
@en
Genetic risk factors for porto ...... s with advanced liver disease.
@nl
P2093
P2860
P1476
Genetic risk factors for porto ...... s with advanced liver disease.
@en
P2093
Daniel Rabinowitz
David B Badesch
Evelyn M Horn
Hocine Tighiouart
Inga Peter
James A Knowles
James F Trotter
Kari E Roberts
Michael B Fallon
Michael J Krowka
P2860
P304
P356
10.1164/RCCM.200809-1472OC
P407
P577
2009-02-12T00:00:00Z